A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015] |
Modak, Shakeel |
|
A Phase II Study of BIND-014 in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-090] |
Scher, Howard |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060] |
Bajorin, Dean |
|
A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer
[Protocol 11-157] |
Paik, Paul |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002] |
Mellinghoff, Ingo |
|
A Phase II Study of BKM120 in Patients with Recurrent or Persistent Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
[Protocol 13-072] |
Younes, Anas |
|
A Phase II Study of Blinatumomab in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-069] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064] |
Hassoun, Hani |
|
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201] |
Hamlin, Paul |
|
A Phase II Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
[Protocol 12-035] |
Horwitz, Steven |
|
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016] |
Giralt, Sergio |
- Blood and Marrow Transplantation
- Hematology
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] |
Drilon, Alexander |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Cabozantinib in Women with Hormone Receptor-Positive Breast Cancer that Spread to the Bone
[Protocol 12-091] |
Fornier, Monica |
|
A Phase II Study of Cabozantinib versus Paclitaxel to Treat Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-048] |
Makker, Vicky |
|
A Phase II Study of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Ependymoma in Adults
[Protocol 11-146] |
Omuro, Antonio |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
|
A Phase II Study of Combination Chemotherapy with and without Low-Dose Whole-Brain Radiation for Primary Central Nervous System Lymphoma
[Protocol 11-125] |
Omuro, Antonio |
- Lymphoma
- Pediatric Brain Tumors
|
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer
[Protocol 10-186] |
Sherman, Eric |
|
A Phase II Study of Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
[Protocol 11-005] |
Lee, Nancy |
|
